Staving Off Type 1 Diabetes with Immune Therapy
Researchers at UCSF are finding success in altering the natural, and previously inexorable, course of type 1 diabetes. Through various drugs, including antibody therapies, the researchers hope to save or preserve the function of insulin-producing beta cells in the pancreas.